Cellino Bio
- Business Model
- B2B
- Total Funding
- $121.0M
- Last Round
- $25.0M GrantSep 2024
- Rounds
- 4
About
Cellino Bio develops AI-driven optical bioprocesses for patient-specific cell therapy manufacturing in regenerative medicine.
Summary
Cellino Bio is an Artificial Intelligence company. It has raised $121.0M in total across 4 rounds, most recently a $25.0M Grant round in Sep 2024. Investors include The Engine, Khosla Ventures and Advanced Research Projects Agency for Health (ARPA-H).
Tech & App Stack
5 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Sep 2024
Sign up to see all 4 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Neuralink is building a brain-computer interface for medical needs and greater human potential.
OpenAI is an AI research and deployment company dedicated to ensuring that general-purpose artifi...
Anthropic is an AI research company that builds reliable, interpretable, and steerable AI systems.
xAI is an AI platform for accelerating human scientific discovery.
Waymo is an autonomous driving technology company with a mission to make it safe and easy for peo...